Cercare Medical Revenue and Competitors
Estimated Revenue & Valuation
- Cercare Medical's estimated annual revenue is currently $6M per year.
- Cercare Medical's estimated revenue per employee is $128,000
- Cercare Medical's total funding is $19M.
Employee Data
- Cercare Medical has 47 Employees.
- Cercare Medical grew their employee count by 4% last year.
Cercare Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Product Owner | Reveal Email/Phone |
Cercare Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.4M | 65 | 41% | N/A | N/A |
#2 | $1.3M | 14 | 17% | $2.83M | N/A |
#3 | $6M | 47 | 4% | $18.9M | N/A |
#4 | $0.7M | 9 | 29% | N/A | N/A |
#5 | $4.5M | 35 | 67% | $3.63M | N/A |
#6 | $5M | 39 | 63% | $3.93M | N/A |
What Is Cercare Medical?
Every patient should benefit from the power of science and advanced technology. We make radiological workflow fast and efficient with our advanced neuroimaging solutions for brain CT and MRI assessment to enable healthcare professionals to act with speed, insight, and confidence – no matter the circumstances.\n\nCercare Medical brings to life technologies you might be missing to eliminate routine post-processing tasks and get unique maps of perfusion and capillary function proven to improve study analysis and speed.\n\nEstablished by researchers from Aarhus University’s MINDLab, which is headed by professor Leif Østergaard, Cercare Medical brings state-of-the-art research insights into actionable results accelerating radiological workflow efficiency.
keywords:N/A
$19M
Total Funding
47
Number of Employees
$6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Aarhus C
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.5M | 51 | 11% | N/A |
#2 | N/A | 55 | 45% | N/A |
#3 | N/A | 57 | 21% | N/A |
#4 | N/A | 58 | 35% | N/A |
#5 | $17.8M | 61 | 45% | N/A |